9 completed. 9 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 9 |
Follow Healthy Men: new trials by email Literature Review of Healthy Men trials Research Report on Healthy Men
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Double-blind, Single-dose, Two-arm Parallel Study to Compare the Pharmacokinetics and Safety of BAT1806 Prefilled Subcutaneous Injection With RoActemra® in Healthy Chinese Male Subjects BAT1806 prefilled subcutaneous injection/RoActemra® (from EU) - Healthy Men | Phase 1 | Completed | Bio-Thera Solutions | 300 | 2023-08-29 | 2025-05-29 |
| A Comparative Pharmacokinetic Study to Evaluate Different Manufacturing Batches of BAT1706 Injection BAT1706 Injection - Healthy Men | Phase 1 | Completed | Bio-Thera Solutions | 38 | 2023-06-15 | 2026-10-01 |
| Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015) Dimethandrolone Undecanoate, Placebo - Healthy Men, Male Contraception | Phase 1 | Completed | Kimberly Myer | 106 | 2017-02-15 | 2025-10-31 |
| Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males Nestorone + Testosterone Combination Gel - Healthy Men, Male Contraception | Phase 1 | Completed | Kimberly Myer | 26 | 2017-01-01 | 2026-02-09 |
| Single Dose, Dose-Ranging Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men Placebo, 11βmethyl nortestosterone dodecylcarbonate - Healthy Men, Male Contraception | Phase 1 | Completed | Premier Research | 12 | 2016-07-14 | 2025-10-31 |
| D2 Dopamine Receptor Occupancy After Oral Dosing of Lu AF35700 in Healthy Men Using [11C]-PHNO as Tracer Compound Part A: Lu AF35700, Part B: Lu AF35700 - Healthy Men | Phase 1 | Completed | H. Lundbeck A/S | 12 | 2014-02-01 | 2014-09-23 |
| Electroencephalography Study Investigating the Effects of Vortioxetine in Healthy Male Subjects Vortioxetine 10 mg, Vortioxetine 20 mg, Escitalopram 15 mg - Healthy Men | Phase 1 | Completed | H. Lundbeck A/S | 32 | 2014-02-01 | 2015-09-01 |
| Phase 1 Study of Dimethandrolone Undecanoate in Healthy Men Dimethandrolone Undecanoate, Placebo - Healthy Men, Male Contraception | Phase 1 | Completed | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 100 | 2012-03-01 | 2025-11-20 |
| A First Time in Man, Study to Assess the Safety of AZD8329 After Single Ascending Oral Doses AZD8329, Placebo - Healthy Men | Phase 1 | Completed | AstraZeneca | 119 | 2009-07-01 | 2010-09-13 |
dimethandrolone-undecanoate (2) · 4-(4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl)benzoic acid (1) · Escitalopram (1) · ST 1435 (1) · Vortioxetine (1) · tocilizumab (1)
Bio-Thera Solutions (2) · H. Lundbeck A/S (2) · Kimberly Myer (2) · AstraZeneca (1) · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (1) · Premier Research (1)
United States (4) · China (2) · France (1) · Sweden (1) · United Kingdom (1)
Christina Wang, MD (4) · Wei Hu, Ph.D (2) · Bradley Anawalt, MD (1) · Stephanie Page Page, MD, PhD (1) · Stephanie Page, MD (1) · Stephanie Page, MD, PhD (1)
PMID 33908182, PMID 27907978, PMID 30252057, PMID 30252061, PMID 30556332, PMID 31976519, PMID 33090208, PMID 41069221